Found 12 matching trials
Study to Assess the Safety and Immunogenicity of a Chikungunya Virus Vaccine Candidate (VLA1553) in Healthy Volunteers PHASE1 Randomized, observer-blinded, multicenter, dose-escalation Phase 1 clinical...
Show More Location
Optimal Research, LLC
Learn More & Join Trial
Pivotal Study to Evaluate Safety and Immunogenicity of a Live-Attenuated Chikungunya Virus Vaccine Candidate in Adults PHASE3 This was a prospective, randomized, double-blinded, multicenter, pivotal cl...
Show More Location
Accelerated Enrollment Solutions (AES)
Learn More & Join Trial
A Multicenter Study to Evaluate Safety and Immunogenicity of a Live-attenuated Chikungunya Vaccine in Adolescents PHASE3 This was a prospective, randomized, double-blinded, multicenter, pivotal st...
Show More Location
CECOR - Centro Oncológico de Roraima
Learn More & Join Trial
A Trial to Evaluate the Safety and Immunogenicity of VLA1553 in Healthy Children PHASE3 VLA1553-322 is a multicenter, prospective, randomized, double-blind, phase ...
Show More Location
Multiple Locations
Learn More & Join Trial
Study to Demonstrate Consistency of Three Lots of a Live-attenuated Chikungunya Virus Vaccine Candidate in Healthy Adults PHASE3 This was a prospective, randomized, double-blinded, multicenter Phase 3 cli...
Show More Learn More & Join Trial
Assessment of Chikungunya Virus Seroprevalence Before VLA1553 Vaccination in the Municipalities Selected for Participation in the VLA1553 Pilot Vaccination Strategy in Brazil N/A This is a cross-sectional serosurvey using household cluster sampling condu...
Show More Status
Active Not Recruiting
Location
Universidade Federal Do Ceará
Learn More & Join Trial
Observational Study to Assess the Effectiveness of VLA1553 Vaccine in Preventing Chikungunya During a Pilot Vaccination Strategy in Brazil N/A This is an observational, non-interventional, test-negative case-control (T...
Show More Status
Enrolling By Invitation
Location
Universidade Federal de Minas Gerais, CT Terapias Avançadas e Inovadoras
Learn More & Join Trial
A Clinical Phase 3 Trial of VLA1553 in Adult Participants with Human Immunodeficiency Virus (HIV) PHASE3 This was a phase 3 clinical study to evaluate the safety, tolerability, and...
Show More Location
Multiple Locations
Learn More & Join Trial
Antibody Persistence And Long Term Safety Of A Chikungunya Virus Vaccine (VLA1553) PHASE3 In this open-label Phase 3b, single arm trial, persistence of antibodies an...
Show More Status
Active Not Recruiting
Location
Accelerated Enrollment Solutions (AES)
Learn More & Join Trial
VLA1553-403 Pregnancy Surveillance Study N/A This post-marketing, observational study evaluates pregnancy and infant out...
Show More Status
Enrolling By Invitation
Location
Universidade Federal de Minas Gerais, CT Terapias Avançadas e Inovadoras
Learn More & Join Trial